FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4324140535> ?p ?o ?g. }

• W4324140535 abstract "Introduction: Albuminuria, an early marker of kidney damage, is a risk factor for chronic kidney disease (CKD) progression, cardiovascular disease (CVD), and death. Dietary sodium is a risk factor for elevated blood pressure, CVD, and all cause-mortality. It is particularly important in patients with CKD due to increased salt-sensitivity. It is unclear if dietary sodium reduction is associated with reduced albuminuria. Hypothesis: A low sodium diet will reduce albuminuria in patients with CKD. Methods: The Sodium Lowering and Urinary Protein Reduction (SUPER) Trial was a randomized, parallel trial testing the effect of a 24-week dietary sodium reduction intervention compared to usual diet on albuminuria in 151 CKD patients with albuminuria. Participants were eligible if they had an estimated glomerular filtration rate (eGFR) of 30-90 mL/min/1.73 m 2 and an albumin-to-creatinine ratio (ACR) of 30-1,500 mg/g. Intervention group participants received a dietician-led behavioral change intervention targeting sodium intake <2,300 mg/day and those in the control group received no dietary intervention. Twenty-four hour urine samples and dietary recalls, blood pressure, weight, and questionnaire data was collected at baseline, 12 weeks and 24 weeks. Mixed effects models were used to examine the intervention effect. Results: Study participants were an average of 65.6 years old, 72% African American, and 48% women. Median baseline ACR was 180.3 mg/g in the intervention and 157.4 mg/g in the control group, respectively. Urinary sodium excretion was reduced by 15.5% and 0.0% in the intervention and control groups, respectively. Results for the primary and key secondary outcomes are presented in the Table. Conclusions: The dietician-led dietary sodium reduction intervention succeeded in significantly reducing dietary sodium and BP in patients with CKD and albuminuria. However, no significant differences were observed in ACR, albuminuria, or eGFR between treatment groups." @default.
• W4324140535 created "2023-03-15" @default.
• W4324140535 creator A5006566521 @default.
• W4324140535 creator A5012250552 @default.
• W4324140535 creator A5019272918 @default.
• W4324140535 creator A5042383916 @default.
• W4324140535 creator A5048379858 @default.
• W4324140535 creator A5048680434 @default.
• W4324140535 creator A5049535333 @default.
• W4324140535 creator A5065023946 @default.
• W4324140535 creator A5066636856 @default.
• W4324140535 creator A5090013547 @default.
• W4324140535 date "2023-02-28" @default.
• W4324140535 modified "2023-10-16" @default.
• W4324140535 title "Abstract 20: Effect of Dietary Sodium Reduction in Chronic Kidney Disease Patients With Albuminuria: Results of a Randomized Trial" @default.
• W4324140535 doi "https://doi.org/10.1161/circ.147.suppl_1.20" @default.
• W4324140535 hasPublicationYear "2023" @default.
• W4324140535 type Work @default.
• W4324140535 citedByCount "0" @default.
• W4324140535 crossrefType "journal-article" @default.
• W4324140535 hasAuthorship W4324140535A5006566521 @default.
• W4324140535 hasAuthorship W4324140535A5012250552 @default.
• W4324140535 hasAuthorship W4324140535A5019272918 @default.
• W4324140535 hasAuthorship W4324140535A5042383916 @default.
• W4324140535 hasAuthorship W4324140535A5048379858 @default.
• W4324140535 hasAuthorship W4324140535A5048680434 @default.
• W4324140535 hasAuthorship W4324140535A5049535333 @default.
• W4324140535 hasAuthorship W4324140535A5065023946 @default.
• W4324140535 hasAuthorship W4324140535A5066636856 @default.
• W4324140535 hasAuthorship W4324140535A5090013547 @default.
• W4324140535 hasConcept C126322002 @default.
• W4324140535 hasConcept C126894567 @default.
• W4324140535 hasConcept C134018914 @default.
• W4324140535 hasConcept C159641895 @default.
• W4324140535 hasConcept C168563851 @default.
• W4324140535 hasConcept C2776174234 @default.
• W4324140535 hasConcept C2778653478 @default.
• W4324140535 hasConcept C2780306776 @default.
• W4324140535 hasConcept C2781203188 @default.
• W4324140535 hasConcept C71924100 @default.
• W4324140535 hasConcept C84393581 @default.
• W4324140535 hasConceptScore W4324140535C126322002 @default.
• W4324140535 hasConceptScore W4324140535C126894567 @default.
• W4324140535 hasConceptScore W4324140535C134018914 @default.
• W4324140535 hasConceptScore W4324140535C159641895 @default.
• W4324140535 hasConceptScore W4324140535C168563851 @default.
• W4324140535 hasConceptScore W4324140535C2776174234 @default.
• W4324140535 hasConceptScore W4324140535C2778653478 @default.
• W4324140535 hasConceptScore W4324140535C2780306776 @default.
• W4324140535 hasConceptScore W4324140535C2781203188 @default.
• W4324140535 hasConceptScore W4324140535C71924100 @default.
• W4324140535 hasConceptScore W4324140535C84393581 @default.
• W4324140535 hasIssue "Suppl_1" @default.
• W4324140535 hasLocation W43241405351 @default.
• W4324140535 hasOpenAccess W4324140535 @default.
• W4324140535 hasPrimaryLocation W43241405351 @default.
• W4324140535 hasRelatedWork W1963155962 @default.
• W4324140535 hasRelatedWork W2004586329 @default.
• W4324140535 hasRelatedWork W2072953734 @default.
• W4324140535 hasRelatedWork W2110052102 @default.
• W4324140535 hasRelatedWork W2113389249 @default.
• W4324140535 hasRelatedWork W2151509478 @default.
• W4324140535 hasRelatedWork W2378222885 @default.
• W4324140535 hasRelatedWork W2616483297 @default.
• W4324140535 hasRelatedWork W3132812123 @default.
• W4324140535 hasRelatedWork W656697013 @default.
• W4324140535 hasVolume "147" @default.
• W4324140535 isParatext "false" @default.
• W4324140535 isRetracted "false" @default.
• W4324140535 workType "article" @default.